Webcast CME

MS Scientific and Practical Considerations for
Individualized Treatment Selection for Patients
with MS



Case 1:
Gina is clinically stable, but she has new MRI lesions;
Case 2: Is Maggie’s RRMS progressing?

Print this Content

Release Date:  January 31, 2017
Expiration Date:   January 30, 2018

Estimated Time of Completion:   1 hour, 15 minutes

Description

Scientific and Practical Considerations for Individualized Treatment Selection for Patients with MS: An Innovative Patient- Centered Learning Experience is a webcast series that provides clinicians with evidence-based knowledge about assessing disease activity and progression, and inform individualized, optimal treatment selection, and communication strategies for patients with multiple sclerosis (MS).

This case-based webcast reviews relapsing remitting and secondary progressive MS.

Learning Objectives

  1. Use pharmacologic profiles to select or switch treatment.
  2. Select treatment in response to the patient’s characteristics and preferences.
  3. Demonstrate understanding of recommended approaches to monitoring disease activity and disease progression.
  4. Apply patient engagement approaches and convey essential information on treatment rationales and side effects.
  5. Highlight the two parallel aspects of MS – active inflammation and gradual progression

Target Audience

This activity is directed to neurologists and pharmacists who care for patients with MS.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Pharmacists

Accreditation Council for Pharmacy Education

The France Foundation is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education and will award 0.13 CEU to pharmacists who complete the activity, complete the registration and evaluation forms, and successfully pass a posttest (>70%). There is no fee to participate in this activity. This is a knowledge educational activity. Your CE credits will be submitted electronically to the CPE Monitor. CE providers must upload participant information within 60 days from the date the participant completed the activity. Please submit all evaluations and credit requests no later than 30 days after you complete this activity to ensure your credit fulfillment, as CE credit cannot be awarded past 60 days from the activity date. ACPE No. 0391-9999-17-001-H01-P.

The France Foundation will submit information for all pharmacists who complete the course. If you have any questions regarding Accreditation Council for Pharmacy Education credit claiming, please contact: Deana Londa, The France Foundation, via email dlonda@francefoundation.com or call 860-598-6081.

Activity Director and Faculty

Activity Director

Alexander D. Rae-Grant, MD
Clinical Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Director of Resident and Student Education
Mellen Center for Multiple Sclerosis Treatment and Research
Cleveland Clinic
Cleveland, OH

Planning Committee

Le Hanh Hua, MD
Eric and Sheila Samson Chair for Multiple Sclerosis Research
Director, Mellen Program for MS
Cleveland Clinic Lou Ruvo Center for Brain Health
Cleveland Clinic
Las Vegas, NV

Kristin Helms, PharmD
Associate Clinical Professor
Pharmacy Practice
Auburn University
Harrison School of Pharmacy
Auburn, AL

Faculty

Robert Bermel, MD
Staff Neurologist and Medical Director
Mellen Center for Multiple Sclerosis
Neurological Institute
Cleveland Clinic
Cleveland, OH

Robert Fox, MD
Staff Neurologist
Mellen Center for Multiple Sclerosis
Neurological Institute
Cleveland Clinic
Cleveland, OH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:



Robert Bermel, MD
  Biogen Idec Consulting
  Genentech/Roche Consulting
  Genzyme Consulting; Teaching and Speaking
  Novartis Consulting
 
Robert Fox, MD
  Actelion Consulting
  Biogen Idec Consulting
  Genentech Consulting
  Mallinckrodt Inc. Consulting
  MedDay Pharmaceuticals Consulting
  Novartis Pharmaceuticals Consulting
  Teva Neurosciences Consulting
  XenoPort Consulting
 
Le Hanh Hua, MD
  Biogen Idec Teaching and Speaking
  Genzyme/Sanofi Consulting; Teaching and Speaking
  Novartis Pharmaceuticals Consulting
  Teva Pharmaceuticals Teaching and Speaking
 

The following faculty have indicated that they have no relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:

Kristin Helms, PharmD
Alexander Rae-Grant, MD

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:
Biogen
Genentech, Inc.

This CME activity was produced by the Cleveland Clinic Center for Continuing Education and The France Foundation